BioSpace News Archive

Kalvist Pharmaceuticals, Inc. a clinical stage pharmaceutical company focused on the discovery, development and commercialization of small molecule protease inhibitors, announced today that it intends to offer shares of common stock in an underwritten public offering.

Pomerantz LLP is investigating claims on behalf of investors of CV Sciences, Inc.

Athletico Physical Therapy has opened a new location on Wednesday, September 5th at 6856 Whitestown Pkwy., Zionsville, IN 46077.

Syndax Pharmaceuticals Inc., . (“Syndax,” the “Company” or “we”) (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that data from the PD-(L)1 refractory non-small cell lung cancer (NSCLC) cohort of ENCORE 601 will be presented at the upcoming International Association for the Study of Lung Cancer

According to the latest market research report released by Technavio, the global remote patient monitoring market is expected to accelerate at a CAGR of almost 16% during the forecast period.

The Southwest National Pediatric Device Consortium recently received a prestigious P50 grant from the U.S. Food & Drug Administration (FDA). The five-year, $6.75M grant began on Sept. 1.

Former Global Head of Immunology at Janssen led development of multiple innovative therapies

Novel, one-time, investigational gene therapy treatment for MPS IIIA focused toward preventing neurocognitive decline

The panel accurately and sensitively detects over 1600 variants of clinical significance

Natural Results Plastic Surgery is pleased to announce they now offer GAINSWave!